Category: MENA

Posted on

JETEX LONDON TO WOW PRIVATE JET FLYERS

Jetex announces its first FBO in London, a top-tier destination for the brand’s robust international expansion

Dubai, United Arab Emirates, May 20, 2022 (GLOBE NEWSWIRE) — London is a natural next destination for Jetex, an award-winning global leader in executive aviation, and it becomes the brand’s 35th international FBO location. Jetex entered in an agreement with Avia Solutions Group to operate the FBO at Hangar 510 at Biggin Hill Airport (EGKB/BQH).

The airport rightfully holds a pride of place in British History. Opened in 1916, the property was vacated by the Royal Air Force in 1992 and has operated as a privately-owned civilian airfield dedicated to business and civilian aviation ever since.

Today, it is recognized as a global center of excellence and the second private jet operation in the UK with 23% of London’s market share after Farnborough (31%) and ahead of Luton (22%). The airport typically connects flights to more than 750 destinations across over 70 countries, with over 90% of destinations being in Europe and 5% long haul.

Jetex London is conveniently located just 12 miles from Canary Wharf and 15 miles from Central London, with helicopter transfers taking passengers to and from the heart of the British capital in just six minutes, with limousine transfers taking less than 50 minutes.

The modern airport runway (1,806 meters) allows most aircraft to operate without payload or range restrictions, including non-stop transatlantic flights.

“We are pleased with our arrival in London. Jetex already has a strong presence in Continental Europe with a flagship private jet terminal at Paris Le Bourget, and the new flagship Jetex London is a natural evolution of our operations. Jetex passengers will enjoy a seamless travel experience complemented by the greatest levels of luxury hospitality, unseen before in the market.” said Adel Mardini, Founder & CEO of Jetex.

Jetex London will offer a suite of flagship services for passengers and crews traveling through the airport. It is a seamless, intuitive and dedicated route for Jetex customers to begin or end their journey in supreme comfort. The on-site U.K. Border Force and customs control will ensure that passengers and crew enjoy an efficient ground experience, while Jetex will also offer assistance with ground transport, hotel accommodation, catering, concierge services and much more.

”We are very delighted to welcome this new partnership with Jetex, one of the top names in executive aviation, and are looking forward to operating in Biggin Hill together. The airport is already one of the key points for Avia Solutions Group, as our subsidiary JETMS Completions is successfully running aircraft interior and exterior completions there. Thus, the partnership is opening even more opportunities for further business expansion as well as collaboration on future projects. We see great things ahead,” said Vygaudas Ušackas, Member of the Board of Directors at Avia Solutions Group.

“Jetex is a globally admired brand and we are proud to have the company join our ecosystem of aviation businesses here at London Biggin Hill Airport. We know Jetex will provide an excellent continuity of service and we are looking forward to seeing them thrive,” said Robert Walters, Commercial Director, London Biggin Hill Airport.

With natural materials, soft lighting, and floor-to-ceiling windows, Jetex London is designed to feel like a warm, contemporary space. The 1,900 sq.m. private terminal will include several supremely comfortable lounges of understated luxury designed with passenger privacy in mind, a cigar lounge, retail and entertainment areas, fully-equipped boardrooms, shower suites and much more. Crews will appreciate a full range of on-site recreational and flight support facilities.

Jetex London marks the company’s first entry into the United Kingdom as it looks forward to growing its operations in the market.

– END –

 

About Jetex:

An award-winning global leader in executive aviation, Jetex is recognized for delivering flexible, best-in-class trip support solutions to customers worldwide. Jetex provides exceptional private terminals (FBOs), aircraft fueling, ground handling and global trip planning. The company caters to both owners and operators of business jets for corporate, commercial and personal air travel. To find out more about Jetex, visit www.jetex.com and follow us on Instagram, Twitter, Facebook, and LinkedIn.

 

About Avia Solutions Group:

Leaders in end-to-end capacity solutions for passenger and cargo airlines worldwide. The Group manages over 100 offices and production facilities globally and is significantly backed by the assets of over 7,000 highly skilled aviation professionals, serving more than 2,000 clients throughout Europe, Asia, North America, Australia, and worldwide.

Attachment

Oleg Kafarov - Director of Portfolio Development & Corporate Communications
Jetex
+971 4 212 4900
Posted on

Centrient Pharmaceuticals announces its achievement of a significant milestone in the clean production of antibiotics

Being the first company to publicly announce 100% PNEC compliance for its entire oral antibiotics product range

Rijswijk, The Netherlands, May 19, 2022 (GLOBE NEWSWIRE) —

Summary

  • Centrient Pharmaceuticals reached a significant milestone in the clean production of its antibiotics, with the lowest environmental impact and minimizing the potential contribution to antimicrobial resistance
  • The company is the first to publicly announce that Its entire supply chain of oral antibiotics – including its own and supplier manufacturing sites – is fully compliant with the stringent Predicted No Effect Concentration (PNEC) discharge targets set by the AMR Industry Alliance
  • This achievement demonstrates Centrient Pharmaceuticals’ commitment and leadership in the responsible production of antibiotics.

Centrient Pharmaceuticals announces 100% compliance with the stringent Predicted No Effect Concentration (PNEC) discharge targets set by the AMR Industry Alliance for clean manufacturing of its full oral antibiotics product range. This standard covers both Centrient’s sites and its suppliers’ sites. This achievement positions the company as a frontrunner in the industry with the delivery of responsibly-produced antibiotics, which minimize the possible contribution to antimicrobial resistance.

The PNEC discharge target is the concentration of an antibiotic in water at which there is unlikely to be a risk of adverse environmental effects or of antimicrobial resistance (AMR) developing. These scientific, risk-based targets were developed by the AMR Industry Alliance and cover around 120 active pharmaceutical ingredients (APIs) used in antibiotic manufacturing. Each individual antibiotic has a corresponding PNEC value, published in the AMR Industry Alliance table of Recommended PNECs for Risk Assessments (updated periodically).

High concentrations of antibiotic residues in factory wastewater can create hotspots of resistant bacteria which may lead to AMR. While manufacturing is just one of the contributors to the emergence of AMR in the environment, its impact cannot be overlooked. AMR is a major threat to global public health as well as to the healthcare industry. Many standard medical procedures such as organ transplants, chemotherapy, and surgeries such as caesarean sections become much more dangerous without effective antibiotics to prevent and treat infections. Antibiotics are the cornerstone of our modern healthcare system, and complying with PNEC standards enables manufacturers to ensure supply of these critically important medicines does not contribute to the risk of AMR.

The PNEC values are increasingly being recognized as the standard for antibiotic discharge concentrations in water and are expanding beyond Alliance companies and their supply chains. For example, tenders in the UK and Germany (health insurer AOK) include a specific reference to the PNEC discharge targets. Also, companies assessed externally by organizations such as the Access to Medicine Foundation will have public exposure for their performance on PNECs.

As a strong advocate for sustainable manufacturing, Centrient Pharmaceuticals became a founding board member of the AMR Industry Alliance in 2017, working with partners to raise awareness and deliver solutions to the AMR issue. Since then, the company’s own journey to reaching full compliance has included establishing state-of-the-art wastewater treatment facilities at all their sites worldwide and developing tests for measuring antibiotic activity in wastewater streams, leading to a fully clean and PNEC-compliant supply chain.

“We are proud to be the first in our industry to publicly announce PNEC compliance for our oral antibiotics product supply chain.

At Centrient Pharmaceuticals, our commitment to Sustainability is in our DNA – we ensure that the way in which we produce pharmaceuticals has the lowest environmental impact and does not contribute to AMR. We are proud of our PureActives® enzymatic low-carbon technology, ISO 14001 certification of all our sites, and Board positions at the Pharmaceutical Supply Chain Initiative and AMR Industry Alliance.

We will continue to work with customers, suppliers, industry and government decision-makers across the value chain to make the supply and buying of antibiotics sustainable to curb AMR.”, says Rex Clements, CEO at Centrient Pharmaceuticals.

Read our whitepaper ‘Manufacturing sustainable antibiotics for the future’ here.

About Centrient Pharmaceuticals

Centrient Pharmaceuticals is the global leader in the production and commercialisation of sustainable antibiotics, next-generation statins, and anti-fungals. We produce and sell intermediates, active pharmaceutical ingredients and finished dosage forms.

We stand proudly at the centre of modern healthcare, as a maker of essential and life-saving medicines. With our commitment to Quality, Reliability and Sustainability at the heart of everything we do, our over 2,200 employees work continuously to meet our customers’ needs. We work towards a sustainable future by actively participating in the fight against antimicrobial resistance.

Founded 150 years ago as the ‘Nederlandsche Gist- en Spiritusfabriek’, our company was known as Gist Brocades and more recently DSM Sinochem Pharmaceuticals. Headquartered in Rijswijk (Netherlands), we have production facilities and sales offices in China, India, the Netherlands, Spain, the United States and Mexico. Centrient Pharmaceuticals is wholly owned by Bain Capital Private Equity, a leading global private investment firm.

For more information please visit www.centrient.com or contact Centrient Pharmaceuticals Corporate Communications, Alice Beijersbergen, Director Branding & Communications. E-Mail: alice.beijersbergen@centrient.com.
About the AMR Industry Alliance

The AMR Industry Alliance was formed in 2017. With approximately 100 life sciences companies and trade associations, it represents nearly one-third of the volume of sales and the majority of all novel products. Members have committed to report on activities they are undertaking in the areas of research & science, access to antibiotics and appropriate use of these, as well as responsible environmental manufacturing to tackle the rapid spread of antimicrobial resistance. If AMR remains unchecked, the annual death toll could climb from 700,000 each year to 10 million by 2050 and the economic impacts could be on par with those of the 2008 financial crisis. The AMR Industry Alliance ensures that signatories collectively deliver on the specific commitments made in the Industry Declaration on AMR and the Roadmap for Progress on Combating AMR and measures progress made in the fight against AMR.
Forward-looking statements

This press release may contain forward-looking statements with respect to Centrient Pharmaceuticals’ future financial performance and position. Such statements are based on current expectations, estimates and projections of Centrient and information currently available to the company. Centrient cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. Centrient has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is governing.

Alice Beijersbergen
Centrient Pharmaceuticals
+31 (6) 823 579 56
alice.beijersbergen@centrient.com
Posted on

Advance Local is New Sophi.io Customer

TORONTO, May 18, 2022 (GLOBE NEWSWIRE) — Advance Local, one of the largest media groups in the United States operating 10 leading news and information organizations and reaching 55 million people monthly, has quadrupled their subscription goal using Sophi Content Paywall Engine. Faced with advertising pressures exacerbated by the Coronavirus, Advance Local increased subscription conversions 45% using Sophi.io, an AI-powered automation, optimization and prediction platform developed by The Globe and Mail. Their success with Sophi has also earned them a spot as a finalist in the Digiday Media Awards, announced this week.

Neil Katz, Chief Customer Officer at Advance Local, said, “We wanted to see how much farther Sophi could take us, so we tested Sophi Content Paywall on one of our largest sites. The results were transformative. We were hoping for a 10% lift in conversion rate and Sophi delivered four times that result. We’re continuing to roll out Sophi solutions across more of our sites as we speak.”

Advance started using Sophi Content Paywall Engine on one of its largest sites, cleveland.com, to get better insights into the value of their content and fuel their new subscription business. The technology uses advanced natural language processing (NLP) to analyze every piece of content and select which articles to put behind a paywall. It picks only those articles where the subscription revenue opportunity outweighs the advertising revenue forgone.

During an experiment where Advance could see how Sophi performed side by side with their existing paywall, Sophi presented roughly the same amount of paywalls and generated a 45% lift in the total conversion rate, while also uncovering pockets of content that editors didn’t anticipate would generate subscriptions.

John Hassell, Senior Vice President and Editorial Director at Advance Local, said, “We wanted to see if Sophi’s content paywall could increase subscriber acquisition by 10% and it blew that goal out of the water. We’re feeling good about the platform and the way it is showing us just how valuable our editorial content is to our audience.”

Advance Local is also a finalist in the Digiday Media Awards, in the category of Best Subscription or Membership Product, for their work using Sophi Content Paywall Engine.

“Advance Local is an incredibly innovative organization that we’ve watched push the boundaries and we’re very excited to be working with them,” said Mike O’Neill, Co-Founder and CEO of Sophi.io. “We’re seeing great value come from the content paywall they’ve implemented and we’re excited to introduce some other cutting edge technology into this very strong brand.”

About Advance Local

Advance Local (www.advancelocal.com) is one of the largest media groups in the United States. It operates 10 leading news and information organizations and reaches 55 million people monthly across multiple platforms with its high-quality journalism. They are dedicated to unrivaled local journalism that improves the lives of millions of people.

About Sophi.io

Sophi.io (https://www.sophi.io) was developed by The Globe and Mail to help content publishers make important strategic and tactical decisions. It is a suite of AI and ML-powered automation, optimization and prediction solutions that include Sophi Site Automation, Sophi for Paywalls and Sophi for First Party Data. Sophi also powers one-click automated laydown of template-free print publishing. Sophi is designed to improve the metrics that matter most to your business, such as subscriber retention and acquisition, engagement, recency, frequency and volume.

Contact Us

Jamie Rubenovitch
Head of Marketing, Sophi.io
The Globe and Mail        
jrubenovitch@globeandmail.com
416-585-3355
Posted on

Landmark Meeting Urges Prioritization of Water and Sanitation to get Health, Climate and Economic Targets Back on Track

JAKARTA, Indonesia, May 18, 2022 /PRNewswire/ — More than 350 participants from 57 countries gathered today in Jakarta for the opening of the Sector Ministers’ Meeting which will generate urgent prioritization of water and sanitation worldwide.

Muyatwa Sitali, SWA Head of Country Engagement and Lucinda O’Hanlon, SWA Head of Policy and Strategy welcome 350 participants to the 2022 Sector Ministers' Meeting on water and sanitation in Jakarta, Indonesia

Among them were 50 ministers of water, sanitation, health, environment and the economy, who met to discuss the COVID-19 pandemic, the climate crisis and a struggling global economy, which have threatened decades of progress on sustainable development. The event was hosted by the Government of Indonesia and convened by the United Nations-hosted Sanitation and Water for All global partnership (SWA) and UNICEF.

Opening the event, Patrick Moriarty, Chair of SWA’s Steering Committee told participants that this triple crisis is deeply intertwined with water and sanitation, making government prioritization of these issues vital.

“Water and sanitation are indispensable for preventing public health emergencies, integral to supporting economic development and imperative for making communities resilient to climate change,” he said.

According to event organizers, access to water and soap will generate $45 billion per year, and reduce the spread of infections in a COVID-19-like epidemic by up to 20 per cent.

Approximately 74 per cent of all natural disasters between 2001 and 2018 were water-related, requiring urgent action. Forty per cent of the global population is highly vulnerable to the impact of climate change.

Additionally, universal access to toilets with safely managed waste will generate $86 billion per year in greater productivity and reduced health costs.

“Water and sanitation are the foundation of all sustainable development – and key to helping children survive and thrive,” said Catherine Russell, Executive Director of UNICEF.  ”When 300,000 children still die every year from diseases linked to unsafe water and inadequate sanitation, we know we need to do more.”

The Sector Ministers’ Meeting will equip political leaders with the evidence and best practices they need to prioritize investments in water and sanitation, which in turn will support the Sustainable Development Goals. It also aims to transform inter-ministerial collaboration at the national level around the human rights to water and sanitation, as well as international learning and cooperation.

It was preceded by a six-month-long preparatory process at both global and national levels, involving 126 governments and organizations.

ABOUT SANITATION AND WATER FOR ALL

Sanitation and Water for All (SWA) is a multi-stakeholder partnership of governments and their partners from civil society, the private sector, UN agencies, research and learning institutions and the philanthropic community. Together, SWA partners stimulate high-level political dialogue – at the country, regional and global levels – and coordinate and monitor progress toward the sanitation, water and hygiene-related targets of the UN Sustainable Development Goals. For more information visit www.sanitationandwaterforall.org.

ABOUT UNICEF

UNICEF works in some of the world’s toughest places, to reach the world’s most disadvantaged children. Across more than 190 countries and territories, we work for every child, everywhere, to build a better world for everyone. UNICEF’s work is funded entirely through the voluntary support of millions of people around the world and our partners in government, civil society and the private sector. Follow UNICEF on Twitter and Facebook.

Photo – https://mma.prnewswire.com/media/1820527/WhatsApp_Image_2022_05_17_at_7_15_02_PM.jpg

Logo – https://mma.prnewswire.com/media/1441352/Sanitation_and_Water_for_All_Logo.jpg

Posted on

WHR Group, Inc. Named a Top Workplace for the Ninth Consecutive Year

MILWAUKEE, Wis., May 17, 2022 (GLOBE NEWSWIRE) — For the ninth consecutive year, WHR Group, Inc. (WHR) was named a Top Workplace by the Milwaukee Journal Sentinel. Top Workplaces surveys employee engagement and satisfaction at companies throughout the US. Awards are given to companies in different regions including the Northeast, Southeast, Midwest, Southwest, Rocky Mountains and the Pacific. Headquartered in Milwaukee, Wisconsin, WHR was awarded a Top Workplace in the Milwaukee and Southeast Wisconsin region.

Top Workplace awards are based solely on the results of employee survey feedback administered by Energage, LLC, a leading research firm that specializes in organizational health and workplace improvement. What makes this award so special, and humbling is that WHR’s employees provided the survey feedback.

WHR Employees and Culture
WHR believes it’s critical to focus on culture in the workplace. As a relocation management company, WHR helps other organizations attract and retain the best talent, which it couldn’t do without finding and retaining the best talent internally.

According to WHR Human Resources Manager, Kimberley Uitz, SHRM-CP, GPHR, “Top Workplaces is an important recognition to any employer, employee or potential employee. In the past few years, this has become more critical, and in some ways harder to obtain. WHR is honored to have earned Top Workplace in 2022 and for our ninth consecutive year. We hope to continue expanding and growing our fantastic employee base.”

WHR wants its employees to enjoy coming into the office, be engaged, be proud of the work they do and grow their careers for success. You can’t have great culture without great people. WHR Group takes the feedback it receives from its employees and acts on it. WHR’s passion has always been Advancing Lives Forward® and WHR embodies this passion for its client’s transferees and its employees.

WHR is proud of this nine-time recognition and its very talented employees.

About WHR Group, Inc.
WHR is a private global employee relocation management company distinguished by its white-glove service delivery structure and proprietary technology. WHR has offices in Wisconsin, Switzerland, and Singapore. With its 100% client retention rate for the past decade, WHR continues to be the trusted leader in global employee relocation. https://www.whrg.com,  LinkedIn, Twitter and Facebook.

Media Contact: Mindy Stroiman, Corporate Writer
Mindy.Stroiman@whrg.com
262-523-7510

Posted on

Zenas BioPharma Submits Investigational New Drug Application in China for ZB001 for the Treatment of Thyroid Eye Disease

WALTHAM, Mass. and SHANGHAI, China, May 15, 2022 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immune-based therapies for patients in need around the world, today announced the submission of an investigational new drug (IND) application to the China National Medical Products Administration (NMPA) for the initiation of a Phase 1/2 clinical study of ZB001 for the treatment of Thyroid Eye Disease (TED). This study is designed to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of ZB001.

“The ZB001 IND submission to the NMPA marks a significant milestone for Zenas,” said Hua Mu, MD, PhD, Chief Executive Officer at Zenas. “There are currently no approved therapies for TED patients in China. Treatment options are limited and often involve high doses of steroids associated with serious side effects or surgical intervention. ZB001 has the potential to change the treatment paradigm for TED patients in China.”

ZB001 is a differentiated humanized monoclonal antibody targeting insulin-like growth factor 1 receptor (IGF-1R) for the treatment of TED. TED is a debilitating autoimmune disease that causes inflammation and fibrosis within the orbit of the eye, which can cause double vision, pain, and potential blindness. Patients with severe disease often require multiple remedial surgeries to the orbit, eye muscles and eyelids.

Zenas BioPharma licensed the exclusive rights to develop, manufacture and commercialize ZB001 (Viridian VRDN-001) and other compounds targeting IGF-1R in non-oncology indications in the greater area of China from Viridian Therapeutics, Inc. (Viridian) in October 2020. In October 2021, Viridian submitted an IND for VRDN-001 to the U.S. Food and Drug Administration and in December 2021 initiated a Phase 1/2 clinical trial to evaluate proof of concept in TED patients in North America.

About Zenas BioPharma

Zenas BioPharma is a global biopharmaceutical company based in the USA and China committed to becoming a leader in the development and commercialization of immune-based therapies for patients in the US, China and around the world. Zenas is rapidly advancing a deep pipeline of innovative therapeutics that continues to grow through our successful business development strategy. Our experienced leadership team and network of business partners drive operational excellence to deliver potentially transformative therapies to improve the lives of those facing autoimmune and rare diseases. For more information about Zenas BioPharma, please visit www.zenasbio.com and follow us on Twitter at @ZenasBioPharma and LinkedIn.

Investor and Media Contact:
Joe Farmer
Zenas BioPharma
IR@zenasbio.com

Posted on

International Day of Families, Angel Yeast encourages households to bake at home.

YICHANG, China, May 15, 2022 /PRNewswire/ — Angel Yeast (en.angelyeast.com, SH600298), a listed global yeast and yeast extract manufacturer, announced on International Day of Families on May 15 that it will continue its longstanding commitment to support and promote a healthy lifestyle for families around the world. Offering a wide range of yeast products, the company aims to inspire and encourage urban households to bake and cook more at home.

International Day of Families, Angel Yeast encourages households to bake at home.

As one of the missions of International Day of Families is to raise awareness regarding the well-being of families, Angel Yeast hopes to start with gastronomy to create discussions globally on how to lead a healthier and more sustainable lifestyle, according to Xishan Wang, deputy general manager at Angel Yeast.

“In recent years we’ve seen a decrease in home baking as busy modern life and the digital era has created more dining options. Young people especially are unwilling to cook so it raises concerns about food safety, nutrition, pollution from plastic packaging, as well as a lack of bonding and family vibe,” said Wang.

Angel Yeast has been taking a leading role in the family consumption of yeast products in China. It has gradually become a major supplier for the global market. Angel Yeast products are used in the making of bread, naan, baozi (steamed stuffed bun), and many other pasties by millions of families throughout the world.

To help and encourage people to do it themselves, Angel Yeast has printed QR codes on some product packages, which allow people to watch an educational cooking video. There is also a range of food DIY training programs for families organized by Angel Yeast around the world all aiming to create opportunities for families to spend more time together.

In addition, Angel Yeast has stepped up efforts in product innovation to offer more options for nutritious diets for families. Product lines include:

  • Bakery products: Angel Yeast has developed a range of safe, nutritious bread and cake mixes. Additionally, its aluminum-free raising agents have been used widely in China.
  • YE (Yeast Extract) flavoring: YE is a natural flavoring that can add more flavors and reduce the use of salts. With efforts from Angel Yeast, 90% of salt-reduced soy sauce in China adds YE to its ingredients.
  • Health care products: Yeast contains nutritious substances for human beings. Angel Yeast has innovated yeast protein technology to produce health care, medical and cosmetic products.
  • Homebrewing and distilling: Another key product line of Angel Yeast is yeast products for home brewing and distilling of beer, wine, and baijiu(rice liquor).

About Angel Yeast

Founded in 1986, Angel Yeast Co., Ltd specializes in the production of yeast and yeast derivatives. Its product range includes baker’s yeast and ingredients, Chinese dim sum and seasoning, savory yeast extract, human health, animal nutrition, plant nutrition, distilled spirits and biofuels, fermentation nutrients, and enzymes. At present, Angel Yeast has 12 international advanced production bases in China, Egypt, and Russia, and provides products and services for more than 160 countries and regions globally.

Photo – https://mma.prnewswire.com/media/1817357/image.jpg

Logo – https://mma.prnewswire.com/media/1586948/angel_logo_Logo.jpg